Trading Report: TherapeuticsMD Inc (TXMD) Research Coverage Started at Oppenheimer Holdings Inc.

TherapeuticsMD Inc (TXMD) Research Coverage Started at Oppenheimer Holdings Inc.

Oppenheimer Holdings Inc. started coverage on shares of TherapeuticsMD Inc (AMEX:TXMD) in a research report released on Tuesday morning, StockTargetPrices.com reports. The brokerage issued an outperform rating on the stock.

TherapeuticsMD (AMEX:TXMD) opened at 7.10 on Tuesday. TherapeuticsMD has a 52 week low of $4.39 and a 52 week high of $11.26. The company’s 50 day moving average is $6.27 and its 200 day moving average is $7.34. The stock’s market cap is $1.40 billion.

About TherapeuticsMD

Related posts

Leave a Comment